You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb2278393 |
---|---|
Category | Small Molecules |
Description | PPARδ agonist 9 (compound 21), with an EC50 of 3.6 nM, effectively decreases serum MCP-1 concentrations in mice and significantly reduces atherosclerotic development in the LDLr-KO model with a 50-60% inhibition rate in vivo [1]. |
Purity | 98.00% |
MW | 569.04 |
Biological Activity | PPARδ agonist 9 (compound 21), with an EC50 of 3.6 nM, is effective in vivo, decreasing serum MCP-1 concentrations in mice and markedly reducing atherosclerotic development in the LDLr-KO model with an inhibition rate of 50-60% [1]. |
CAS Number | 928023-21-6 |
Formula | C26H28ClF3N4O3S |
SMILES | C(COC1=CC(CC(O)=O)=CC(Cl)=C1)C2(CCN(CC2)C=3SC=4C(N3)=CC=C(C(F)(F)F)N4)N5CCCC5 |
Storage | -20°C |
Note | For research use only |
> 98% (HPLC) | |
79558-09-1 | |
402.4 | |
C22H26O7 |